Dennis Wong
Genentech, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dennis Wong as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:12 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT00777764 · The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)Genentech, Inc. · completed · Healthy, Asthma · study director
- Ph2NCT00434434 · A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic AsthmaGenentech, Inc. · completed · Allergic Asthma · study director
- Ph2NCT00382148 · A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788gGenentech, Inc. · completed · Peanut Hypersensitivity · study director
- N/ANCT00252135 · A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe AsthmaGenentech, Inc. · completed · Asthma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:12 UTC. The ranking covers the 200 most relevant of 334 PubMed records, and a shared surname and initials can bring in a namesake. All 334 on PubMed
- In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).J Nucl Med · 2010554 citationsRCR 16.5
- Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.Ann Intern Med · 2011467 citationsRCR 13.5
- Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.Lancet Oncol · 2020419 citationsRCR 18.5
- Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.N Engl J Med · 2015379 citationsRCR 14.1
- Brown Adipose Tissue Activation Is Linked to Distinct Systemic Effects on Lipid Metabolism in Humans.Cell Metab · 2016286 citationsRCR 10.1
- A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.J Allergy Clin Immunol · 2011285 citationsRCR 9.6
- Sex differences in striatal dopamine release in healthy adults.Biol Psychiatry · 2006278 citationsRCR 7.9
- SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study.Cancer Discov · 2018277 citationsRCR 8.1
- Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.Lancet Oncol · 2017275 citationsRCR 10.0
- Subretinal Visual Implant Alpha IMS--Clinical trial interim report.Vision Res · 2015263 citationsRCR 10.6